2024-10-19 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis Report

**1. Performance vs. S&P 500 (VOO)**

HCA Healthcare Inc. (HCA) is a leading provider of healthcare services in the United States, operating hospitals and other healthcare facilities across the country. 

* **Cumulative Return:** HCA has generated a cumulative return of 344.39%, significantly outperforming the S&P 500's return of 137.88%. 
* **Relative Divergence:** HCA has consistently outperformed the S&P 500, with a current relative divergence of 206.51, placing it at the 100th percentile of its historical performance range.

**2. Recent Price Action**

* **Closing Price:** $415.54
* **5-Day Moving Average:** $405.66
* **20-Day Moving Average:** $399.02
* **60-Day Moving Average:** $385.78

HCA's price is currently above all three moving averages, suggesting a bullish trend.

**3. Technical Indicators Analysis**

* **RSI:** 56.14 - HCA's RSI is slightly above the neutral level of 50, indicating moderate bullish momentum.
* **PPO:** 0.36 - The positive PPO value suggests a bullish trend.
* **Delta_Previous_Relative_Divergence:** 0.69 - The positive value indicates a short-term upward trend in relative divergence, implying potential continued outperformance.
* **Expected Return:** 0.0% -  The expected return suggests a potential for HCA to deliver long-term (2 years or more) returns comparable to the S&P 500.

**4. Recent Earnings and Outlook**

HCA's recent earnings have been strong, exceeding expectations:

| Date       | EPS      | Revenue        |
|------------|----------|----------------|
| 2024-07-29 | 5.6     | $17.49 Billion |
| 2024-05-02 | 6.01    | $17.34 Billion |
| 2023-10-26 | 3.98    | $16.21 Billion |
| 2023-08-02 | 4.35    | $15.86 Billion |
| 2024-07-29 | 4.35    | $15.86 Billion |

The latest earnings announcement on 2024-07-29 saw EPS exceeding analysts' expectations. HCA's strong revenue growth and profitability are positive signs for its future performance.

**5. News and Recent Issues**

Recent market outlook for HCA is positive, with analysts citing its robust growth in patient volumes, operational efficiency improvements, and strong market position as key drivers. 

* **Analyst Opinions:**  A majority of analysts are bullish on HCA's stock, with price targets ranging from $450 to $500. 
* **Performance Highlights:** HCA has consistently delivered above-average returns, outperforming the S&P 500 and its peers in the healthcare sector.

**6. Overall Analysis**

HCA Healthcare Inc. (HCA) exhibits strong fundamentals, backed by its market leadership, robust financial performance, and favorable outlook. The stock's recent price action, technical indicators, and analyst sentiments suggest a potentially favorable investment opportunity. HCA's consistent outperformance and positive growth trajectory suggest a potential for continued value creation for long-term investors.

**7. Recommendation**

HCA is a solid investment option for investors seeking exposure to the healthcare sector.  Its strong performance, positive outlook, and robust financial position make it a compelling stock to consider. However, investors should always conduct their own thorough research and consider their individual investment goals and risk tolerance before making any investment decisions.
